Headshot of Medical Reviewer, Muaiad Kittaneh, MDAbout Muaiad Kittaneh, MD, FACP, MBA

Dr. Muaiad Kittaneh, MD, FACP, MBA, is a medical oncologist and assistant professor at Loyola University of Chicago. His journey in healthcare includes Internal Medicine training at Advocate Christ Medical Center/University of Illinois of Chicago, where he excelled as Chief Resident. Dr. Kittaneh further honed his expertise at the University of Miami.

Dr. Kittaneh has conducted extensive research and assisted in many clinical trials. His notable contributions have been published in journals across the United States, which focus particularly on breast, melanoma, and gastrointestinal cancers. As an expert medical reviewer, Dr. Kittaneh plays a crucial role in shaping and evaluating Mesothelioma Hub’s content, ensuring accuracy and relevance in the field.

Muaiad Kittaneh Publications and Experience

Dr. Muaiad Kittaneh has contributed to many publications while acting as a medical oncologist and assistant professor at Loyola University of Chicago. His notable works include a retrospective cohort study from China exploring the predictive role of KRAS mutations in advanced non-small cell lung carcinoma undergoing PD-1 blockade immunotherapy with platinum-based chemotherapy.

Additionally, his research extends to the medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations. These publications provide valuable insights into critical aspects of mesothelioma care. Explore his publications in detail on his Research Gate profile:

  • Hematology
    American Board of Internal Medicine, 2012
  • Medical Oncology
    American Board of Internal Medicine, 2012
  • Internal Medicine
    American Board of Internal Medicine, 2009
  • The University of Miami Leonard M. Miller School of Medicine
    Fellowship, Hematology/Oncology, 2012
  • University of Illinois College of Medicine at Peoria
    Residency, Internal Medicine, 2008
  • Al-Quds University
    Medical Education, 2001